Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery

E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis

11 p | 5 | 3

Clinical impact of tetracyclines and/ or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: A retrospective cohort study

12 p | 1 | 1

The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation

8 p | 13 | 1

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: A retrospective study in 107 patients

7 p | 18 | 1

UPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R

12 p | 14 | 1

Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs

9 p | 21 | 1

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

6 p | 20 | 0

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

7 p | 3 | 0

High frequency of epidermal growth factor receptor mutations in non - small cell lung cancers in Vietnam

12 p | 21 | 0